Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,801 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Phase III B in Acute Lymphoblastic Leukemia

NCT03123939

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Ghent, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details
Completed

A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

NCT01743989

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +17 more
Locations
  • Novartis Investigative Site Linz, Upper Austria, Austria
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Linz, Austria
View all 208 locations
View Trial Details
Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

NCT00109707

Conditions
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
View all 101 locations
View Trial Details
Completed

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

NCT01822509

Conditions
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

NCT01643408

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange County, California, United States
  • Stanford Medical Center Palo Alto, California, United States
  • Children's Hospital Aurora, Colorado, United States
View all 22 locations
View Trial Details

Related conditions